Skip to main content
2024 AANS Annual Scientific Meeting Main banner
Back

Isabelle Germano, MD, MBA

Professor
Mount Sinai Health System
New York, New York, United States

Dr. Germano is a board-certified neurosurgeon who specializes in the most advanced research and treatment of patients with brain tumors. She is a Professor of Neurosurgery, Neurology, and Oncological Sciences at the Icahn School of Medicine at Mount Sinai in New York City. She serves as Director of The Mount Sinai Comprehensive Brain Tumor Program, as well as Co-Director of the Radiosurgery Program and Vice Chair for Diversity and Inclusion in the Department of Neurosurgery for Mount Sinai Health System. In her clinical practice, Dr. Germano focuses on providing multi-disciplinary care, rooted in minimally invasive procedures, for brain and spine tumor patients. Her pioneering work in the field includes first-in-human technology applications for computer-assisted, image-guided neurosurgery. Dr. Germano’s translational research focuses on delivery of gene therapy for brain tumors and she has been awarded multiple grants from the National Institutes of Health, the U.S. Food and Drug Administration, the National Cancer Institute, and private foundations to advance her research. She is also internationally-recognized as a neurosurgery educator, having organized, directed, and/or served as an instructor for nearly 300 practical courses for neurosurgeons and trainees in the United States and abroad. Dr. Germano is the recipient of more than 50 awards recognizing her career as a leader in neurosurgery. She published over 200 peer-reviewed papers and six books. She serves as AANS/CNS Section on Tumor Chair (2022-2024), AANS Global Commitee Inaugural Cahir (2023-2026), AANS/CNS Section on Women previous Chair, World Federation of Neurosurgical Societies (WFNS) Chair, Education and Training (2017-2022), and has held more than 30 other leadership positions within neurosurgical societies, governmental agencies and other professional organizations.

Disclosure(s): Brainlab: Consultant (Ongoing); elminda: Stock Shareholder (excluding mutual funds) (Ongoing)

Presentation(s):